Non-invasive Neuromodulation NESA Through Somatosensory Evoked Potentials and Sympathetic-cutaneous Responses

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUniversity of Las Palmas de Gran Canaria

About this trial

Somatosensory evoked potentials are crucial in determining the physiological changes of potentials in nerve pathways. Although their main function is diagnostic, the investigators have recently been used as a physiological test to determine physioelectric changes in healthy subjects to study applied stimuli, such as laser, pain or electrotherapy.

Eligibility criteria

Qualifiers

Healthy people

Optimal cognitive abilities and mentally competent to participate in the study.

In condition to complete the study questionnaires.

Disqualifiers

Focal mononeuropathies in both upper and lower limbs

Peripheral neuropathy.

Patients with implanted functioning pacemakers / defibrillators. Patients with bleeding disorders. Patients being treated with anticoagulants. Patients on antiplatelet therapy.

Present some of the contraindications for a treatment with NESA XSIGNAL®: pacemakers, internal bleeding, do not apply electrodes on skin in bad condition, with ulcerations or wounds, acute febrile processes, acute thrombophlebitis and / or electricity phobia.

Trial design

Treatments tested in this trial

  • Non-invasive Neuromodulation

Treatment groups

15 Participants
are divided into 1 treatment group

Locations

This trial has no locations